Bupivacaine for Postoperative Pain
(QoR-SCPB Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn whether a superficial cervical plexus block improves quality of recovery after thyroid surgery. Investigators will compare a superficial cervical plexus block with bupivacaine compared to an identical procedure performed saline placebo to see if there is a difference in quality of recovery on the first postoperative day. The main question to answer is: • Does a superficial cervical plexus block with bupivacaine compared to placebo improve quality of recovery in patients having thyroid surgery. Participants will: * Fill out an initial preoperative survey * Be randomized to receive a superficial cervical plexus block with bupivacaine or saline placebo while under anesthesia before the surgery starts * Fill out a survey about recovery on the first day after surgery
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for postoperative pain?
Is bupivacaine safe for use in humans?
How does bupivacaine differ from other drugs for postoperative pain?
Bupivacaine is unique because it is often used in a superficial cervical plexus block, which is a type of regional anesthesia that targets nerves in the neck to reduce pain after surgeries like thyroidectomy. This method can provide effective pain relief with potentially fewer systemic side effects compared to general anesthesia or systemic pain medications.1291011
Research Team
Eligibility Criteria
This trial is for adults over 18 who are scheduled for thyroid surgery, can access a smartphone or computer with internet, and are willing to follow the study's procedures. They must be classified as ASA Physical Status I-III, indicating they have mild to moderate systemic disease but not incapacitating.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Assessment
Participants fill out an initial preoperative survey and are randomized to receive a superficial cervical plexus block with bupivacaine or saline placebo under anesthesia before surgery
Surgery and Immediate Postoperative Care
Participants undergo thyroid surgery and receive either bupivacaine or saline placebo. Postoperative care includes monitoring in the PACU with assessments for rescue antiemetics, analgesia, and opioid consumption
Postoperative Day 1 Assessment
Participants complete the Quality of Recovery-40 (QoR-40) questionnaire to assess recovery quality on the first postoperative day
Follow-up
Participants are monitored for any side effects and report on the quantity of analgesia used through postoperative day 1
Treatment Details
Interventions
- Bupivacaine (Other)
- Placebo (Other)
- Superficial Cervical Plexus Block (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Nancy J. Brown
Yale University
Chief Medical Officer since 2020
MD from Yale School of Medicine
Peter Salovey
Yale University
Chief Executive Officer since 2013
PhD in Psychology from Yale University